DepoMed Inc. (DEPO) Tops Q1 Views
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Join SI Premium – FREE
After the close, DepoMed Inc. (NASDAQ: DEPO) reported Q1 EPS of $1.77, $0.72 better than the analyst estimate of $1.05. Revenue for the quarter came in at $83.1 million versus the consensus estimate of $81.42 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
